Skip to main content
. 2020 Feb 18;12(2):170. doi: 10.3390/pharmaceutics12020170

Scheme 2.

Scheme 2

Synthetic routes for poly (N,N-diethylaminoethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) (PDEAEMA-PPEGMA) (A) and polycaprolactone-b-poly (poly(ethylene glycol) methyl ether methacrylate) (PCL-PPEGMA) (B).